Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study's location information was reorganized: a consolidated 'Locations' section was added, and the per-state subsections for California, Louisiana, New York, Ohio, and Texas were removed (revision v3.3.3).
    Difference
    0.7%
    Check dated 2025-12-23T17:32:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Deleted the funding/operating-status notice banner at the top of the study record page; the remaining study content is unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:40:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    No significant changes to core content were detected; the updates appear to be minor editorial or formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:17:40.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    3%
    Check dated 2025-10-06T04:14:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-28T23:35:29.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.